Cargando…

Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study

BACKGROUND: Since the emergence of COVID-19 there have been increasing global concerns about delays and/or discontinuations in cancer care. However, it is unclear to what extent systemic cancer therapy was impacted by COVID-19 in countries with relatively low COVID-19 infection rates. We examined ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Monica, Daniels, Benjamin, Aslam, Maria, Schaffer, Andrea, Pearson, Sallie-Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329989/ https://www.ncbi.nlm.nih.gov/pubmed/34368796 http://dx.doi.org/10.1016/j.lanwpc.2021.100226

Ejemplares similares

Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia
por: Bruno, Claudia, et al.
Publicado: (2020)

Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016
por: Daniels, Benjamin, et al.
Publicado: (2020)

Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
por: Daniels, Benjamin, et al.
Publicado: (2017)

Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)
por: Tang, Monica, et al.
Publicado: (2019)

Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)
por: Tang, Monica, et al.
Publicado: (2020)

Comparison of claims from high–drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
por: Tadrous, Mina, et al.
Publicado: (2021)

Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
por: Camacho, Ximena, et al.
Publicado: (2022)

A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort
por: Daniels, Benjamin, et al.
Publicado: (2017)

Persistence and Adherence to Cardiovascular Medicines in Australia
por: de Oliveira Costa, Juliana, et al.
Publicado: (2023)

Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015)
por: Daniels, Benjamin, et al.
Publicado: (2019)

Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study
por: Daniels, Benjamin, et al.
Publicado: (2023)

Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)
por: Daniels, Benjamin, et al.
Publicado: (2018)

Comparison of Prescribing Patterns Before and After Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2019)

Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia
por: Brett, Jonathan, et al.
Publicado: (2018)

Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort
por: Daniels, Benjamin, et al.
Publicado: (2021)

Metastatic breast cancer incidence, site and survival in Australia, 2001–2016: a population-based health record linkage study protocol
por: Lord, Sarah J, et al.
Publicado: (2019)

The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians
por: Pearson, Sallie-Anne, et al.
Publicado: (2014)

Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants
por: Morgan, Alice, et al.
Publicado: (2018)

Dispensing Practices of Fixed Dose Combination Controller Therapy for Asthma in Australian Children and Adolescents
por: Homaira, Nusrat, et al.
Publicado: (2020)

Living with COVID-19 and cancer: the need for observational research in the post-pandemic world
por: Daniels, Benjamin, et al.
Publicado: (2023)

Evidence‐practice gaps in P2Y(12) inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population‐level data linkage in Australia
por: Falster, Michael O., et al.
Publicado: (2022)

Patterns of immediate breast reconstruction in New South Wales, Australia: a population‐based study
por: Feng, Yingyu, et al.
Publicado: (2019)

Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia
por: Havard, Alys, et al.
Publicado: (2021)

Incidence and risk factors of hypertension therapy in Australian cancer patients treated with vascular signalling pathway inhibitors
por: Hong, Soojung, et al.
Publicado: (2022)

Hospital characteristics associated with low-value care in public hospitals in New South Wales, Australia
por: Badgery-Parker, Tim, et al.
Publicado: (2020)

The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers
por: Mellish, Leigh, et al.
Publicado: (2015)

Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions
por: Schaffer, Andrea L., et al.
Publicado: (2021)

The changing face of Australian data reforms: impact on pharmacoepidemiology research
por: de Oliveira Costa, Juliana, et al.
Publicado: (2021)

Changes in antibiotic prescribing following COVID‐19 restrictions: Lessons for post‐pandemic antibiotic stewardship
por: Gillies, Malcolm B., et al.
Publicado: (2021)

How the mental health of working parents in Australia changed during COVID-19: A pre- to during pandemic longitudinal comparison
por: Leach, Liana, et al.
Publicado: (2023)

The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia
por: Degenhardt, Louisa, et al.
Publicado: (2015)

Trends in self-poisoning and psychotropic drug use in people aged 5–19 years: a population-based retrospective cohort study in Australia
por: Cairns, Rose, et al.
Publicado: (2019)

A critical care pandemic staffing framework in Australia
por: Marshall, Andrea P., et al.
Publicado: (2021)

Poor appetite and overeating reported by adults in Australia during the coronavirus-19 disease pandemic: a population-based study
por: Owen, AJ, et al.
Publicado: (2020)

Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006–2014)
por: Daniels, Benjamin, et al.
Publicado: (2018)

Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
por: Gisev, Natasa, et al.
Publicado: (2023)

Five-Year Trajectories of Prescription Opioid Use
por: Gisev, Natasa, et al.
Publicado: (2023)

Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: A narrative review
por: Panwala, Victoria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6tsnuhnd7t340ahmvgo5q9r9gn